Leila Eshraghi
Garvan Institute of Medical Research, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Evaluation of novel therapies targeting the p53 and apoptotic pathways in treatment-resistant estrogen receptor-positive breast cancer (#154)
1:00 PM
Fiona H Zhou
Lunch & Poster Viewing (Even Numbers)
Telomere remodelling in drug resistant ER+ breast cancer (#113)
12:45 PM
Leila Eshraghi
Lunch & Poster Viewing (Odd Numbers)